Rosetta Genomics Announces it has Presented Data on Advancements Made in the Company's Lead Assay Development Program for Cancer of Unknown Primary (CUP)

REHOVOT, Israel and NEW BRUNSWICK, New Jersey, April 20

Apr 20, 2007, 01:00 ET from Rosetta Genomics Ltd

$countyNameToPathMap.put("sp